Mechanism of Action PDF Print E-mail
Phospholipids, indicated here in green, are normal molecular structures that are present in all cells of the human body.
Scientists working with Peregrine discovered that on tumor vasculature...
...certain phospholipids normally found on the inside of cell membranes become exposed on the outer surfaces of tumor blood vessels.
Bavituximab is a patented monoclonal antibody that targets these phospholipids.
Once bound to the tumor blood vessels, bavituximab reactivates and directs the body's immune system to attack the tumor and its blood supply...
Stopping the flow of oxygen and nutrients to the tumor cells, resulting in tumor cell death

 

Read more about bavituximab’s broad therapeutic potential

Clinical data on Bavituximab
 
Copyright © 2003-2012 Peregrine Pharmaceuticals Inc., All Rights Reserved